Coagulation factor F11
Coagulation factor F11
2026-02-02
Coagulation factor XI (F11), also known as plasma prothrombin (PTA), or FXI, is a serine protease primarily synthesized in the liver, with lower rates of production in the pancreas...
Leukemia inhibitory factor LIF
Leukemia inhibitory factor LIF
2026-02-02
Leukemia inhibitory factor (LIF), also known as differentiation-stimulating factor or melanoma-derived LPL inhibitor (MLPLI), is a pleiotropic protein belonging to the interleukin-...
Angiogenesis regulatory target TNC
Angiogenesis regulatory target TNC
2026-01-27
Tenascin (TNC) is a cytosmal matrix-rich glycoprotein. Extracellular matrix proteins participate in guiding neuronal and axonal migration during development and are also associated...
Nervous system regulatory factor LINGO1
Nervous system regulatory factor LINGO1
2026-01-26
LINGO1 belongs to the Nogo receptor complex and influences oligodendrocyte differentiation, axonal regeneration, and neuronal survival, playing a crucial role in central nervous sy...
Coagulation pathway promoter CD142
Coagulation pathway promoter CD142
2026-01-26
Tissue factor (CD142), also known as coagulation factor III, F3, or CD142, initiates the blood clotting process by forming a complex with circulating factor VII or VIIa. The CD142/...
Emerging immune regulatory target BTN1A1
Emerging immune regulatory target BTN1A1
2026-01-20
BTN1A1 has been shown to inhibit T cell activation both in vitro and in vivo. Strong BTN1A1 expression was detected in a range of solid tumor tissue samples, and its expression is ...
Tumor microenvironment homeostasis regulator CLU
Tumor microenvironment homeostasis regulator CLU
2026-01-19
Clusterin (CLU), also known as complement cell lysis inhibitor (CLI), apolipoprotein J (APOJ), complement-associated protein SP-40, or aging-associated gene 4 protein (AAG4), parti...